@article{9de7033fcd6b4e498cebf07c84ed9ab6,
title = "Metronidazole exposure–response and safety in infants",
keywords = "metronidazole, pediatric, pharmacodynamics, safety, Humans, Enterocolitis, Necrotizing/drug therapy, Infant, Male, Metronidazole/therapeutic use, Female, Anti-Bacterial Agents/therapeutic use, Infant, Newborn, Intraabdominal Infections/drug therapy",
author = "\{Best Pharmaceuticals for Children Act\} and \{Pediatric Trials Network Steering Committee\} and Randell, \{Rachel L.\} and Balevic, \{Stephen J.\} and Greenberg, \{Rachel G.\} and Michael Cohen-Wolkowiez and Smith, \{Michael J.\} and Benjamin, \{Daniel K.\} and Catherine Bendel and Bliss, \{Joseph M.\} and Hala Chaaban and Rakesh Chhabra and Dammann, \{Christiane E.L.\} and Downey, \{L. Corbin\} and Hornik, \{Chi D.\} and Naveed Hussain and Laughon, \{Matthew M.\} and Adrian Lavery and Fernando Moya and Matthew Saxonhouse and Sokol, \{Gregory M.\} and Andrea Trembath and Weitkamp, \{Joern Hendrik\} and Hornik, \{Christoph P.\}",
note = "Publisher Copyright: Copyright {\textcopyright} 2025 Randell et al.",
year = "2025",
month = nov,
doi = "10.1128/aac.00377-25",
language = "English",
volume = "69",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
number = "11",
}